Chatham Capital Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,873
| Closed | -$202K | – | 203 |
|
|
2024
Q3 | $202K | Hold |
1,873
| – | – | 0.03% | 194 |
|
|
2024
Q2 | $203K | Hold |
1,873
| – | – | 0.04% | 189 |
|
|
2024
Q1 | $247K | Sell |
1,873
-810
| -30% | -$101K | 0.05% | 180 |
|
|
2023
Q4 | $327K | Hold |
2,683
| – | – | 0.07% | 162 |
|
|
2023
Q3 | $301K | Hold |
2,683
| – | – | 0.07% | 164 |
|
|
2023
Q2 | $391K | Hold |
2,683
| – | – | 0.08% | 152 |
|
|
2023
Q1 | $347K | Sell |
2,683
-600
| -18% | -$75.3K | 0.08% | 159 |
|
|
2022
Q4 | $419K | Hold |
3,283
| – | – | 0.1% | 151 |
|
|
2022
Q3 | $343K | Hold |
3,283
| – | – | 0.08% | 151 |
|
|
2022
Q2 | $345K | Sell |
3,283
-166
| -5% | -$19.7K | 0.08% | 152 |
|
|
2022
Q1 | $441K | Sell |
3,449
-905
| -21% | -$109K | 0.09% | 145 |
|
|
2021
Q4 | $537K | Hold |
4,354
| – | – | 0.1% | 143 |
|
|
2021
Q3 | $619K | Hold |
4,354
| – | – | 0.12% | 137 |
|
|
2021
Q2 | $680K | Hold |
4,354
| – | – | 0.13% | 132 |
|
|
2021
Q1 | $677K | Buy |
+4,354
| New | +$674K | 0.14% | 127 |
|
|
2020
Q3 | – | Sell |
-2,670
| Closed | -$309K | – | 154 |
|
|
2020
Q2 | $309K | Hold |
2,670
| – | – | 0.08% | 135 |
|
|
2020
Q1 | $262K | Hold |
2,670
| – | – | 0.08% | 140 |
|
|
2019
Q4 | $388K | Hold |
2,670
| – | – | 0.1% | 135 |
|
|
2019
Q3 | $356K | Hold |
2,670
| – | – | 0.09% | 131 |
|
|
2019
Q2 | $305K | Hold |
2,670
| – | – | 0.08% | 140 |
|
|
2019
Q1 | $331K | Hold |
2,670
| – | – | 0.09% | 137 |
|
|
2018
Q4 | $269K | Hold |
2,670
| – | – | 0.07% | 139 |
|
|
2018
Q3 | $341K | Hold |
2,670
| – | – | 0.09% | 127 |
|
|
2018
Q2 | $289K | Hold |
2,670
| – | – | 0.08% | 127 |
|
|
2018
Q1 | $283K | Hold |
2,670
| – | – | 0.08% | 123 |
|
|
2017
Q4 | $313K | Buy |
2,670
+289
| +12% | +$32.7K | 0.09% | 121 |
|
|
2017
Q3 | $271K | Hold |
2,381
| – | – | 0.08% | 131 |
|
|
2017
Q2 | $297K | Hold |
2,381
| – | – | 0.08% | 131 |
|
|
2017
Q1 | $282K | Hold |
2,381
| – | – | 0.08% | 130 |
|
|
2016
Q4 | $239K | Hold |
2,381
| – | – | 0.07% | 128 |
|
|
2016
Q3 | $301K | Buy |
2,381
+48
| +2% | +$5.93K | 0.1% | 120 |
|
|
2016
Q2 | $273K | Hold |
2,333
| – | – | 0.08% | 126 |
|
|
2016
Q1 | $242K | Hold |
2,333
| – | – | 0.08% | 127 |
|
|
2015
Q4 | $232K | Hold |
2,333
| – | – | 0.07% | 131 |
|
|
2015
Q3 | $213K | Hold |
2,333
| – | – | 0.07% | 133 |
|
|
2015
Q2 | $247K | Hold |
2,333
| – | – | 0.07% | 137 |
|
|
2015
Q1 | $266K | Hold |
2,333
| – | – | 0.08% | 146 |
|
|
2014
Q4 | $257K | Hold |
2,333
| – | – | 0.08% | 145 |
|
|
2014
Q3 | $228K | Hold |
2,333
| – | – | 0.07% | 147 |
|
|
2014
Q2 | $235K | Hold |
2,333
| – | – | 0.09% | 103 |
|
|
2014
Q1 | $214K | Hold |
2,333
| – | – | 0.09% | 105 |
|
|
2013
Q4 | $211K | Buy |
+2,333
| New | +$202K | 0.09% | 110 |
|
Other funds holding ZBH
Chatham Capital Group's ZBH Position: Q4 2024 in Review
Chatham Capital Group sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 1,873 shares — an estimated $202K sold.
Chatham Capital Group first reported a position in ZBH in Q4 2013 and held it in 42 quarters. The position peaked at $680K in Q2 2021. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.
- Chatham Capital Group reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
- Chatham Capital Group sold 1,873 Zimmer Biomet shares in Q4 2024, an estimated $202K.
- Chatham Capital Group first reported a position in Zimmer Biomet in Q4 2013 and held it in 42 quarters.
- Chatham Capital Group's Zimmer Biomet position peaked at $680K in Q2 2021.
- 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.
Based on Chatham Capital Group's 13F filing for Q4 2024, filed 7 Feb 2025.